Genmab | Costo Del Venduto

Cost Of Sales Cambiamento Data
Agios Pharmaceuticals USD 586K 47K 2023-12
Almirall EUR 106.37M 15.74M 2023-06
Amarin USD 23.56M 361K 2023-09
Amgen USD 3.11B 1.31B 2023-12
AstraZeneca USD 2.06B 91M 2023-09
Bayer EUR 4.81B 94M 2023-09
Demant DKK 2.98B 360M 2023-06
Fresenius Medical Care EUR 3.71B 79M 2023-09
Galapagos EUR 5.7M 1.43M 2023-09
GN Store Nord DKK 2.21B 51M 2023-09
GRIFOLS EUR 1.08B 114.07M 2023-12
Hikma Pharmaceutical USD 694M 32M 2023-06
Insmed USD 18.44M 1.74M 2023-12
Lonza CHF 1.97B 29M 2023-06
Regeneron Pharmaceuticals USD 517M 80.6M 2023-12
Roche Holding CHF 7.62B 1.33B 2023-06
UCB EUR 802M 27M 2023-06



Genmab Costo Del Venduto - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2024.